<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01196767</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0080</org_study_id>
    <nct_id>NCT01196767</nct_id>
  </id_info>
  <brief_title>Ropivacaine Though Laterosternal Catheters After Cardiac Surgery</brief_title>
  <official_title>Postoperative Analgesia After Cardiac Surgery: Effects of a Continuous Infusion of Ropivacaine Through Laterosternal Catheters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      This is a prospective double-blinded and randomised study involving patients undergoing
      cardiac surgery with median sternotomy, the effects on postoperative analgesia of a 48-hr
      continuous infusion of ropivacaine 2 mg.mL-1, at the rate of 4 mL.hr-1 through two catheters
      inserted at the lateral edges of the sternum will be studied, versus a control group in which
      normal saline will be infused in the same conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diverse methods for infusion of local anaesthetics after cardiac surgery have been proposed,
      but none of them provided high-level evidence of efficacy. The catheters studied here are
      designed for a surgical insertion before closure of the sternotomy, with the aim of infusing
      the drug the closest possible of the terminations of intercostal nerves.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score at mobilization (lying position for measurement of central venous pressure), expressed on a visual analogue scale.</measure>
    <time_frame>every 4 hours during 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morphine consumption on PCA device</measure>
    <time_frame>every 4 hours during 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score at rest, expressed on a visual analogue scale.</measure>
    <time_frame>every 4 hours during 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital capacity and inspiratory reserve volume, related to the preoperative values</measure>
    <time_frame>daily during 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative blood level of troponin</measure>
    <time_frame>every 8 hours during 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gases</measure>
    <time_frame>every 4 hours during 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first flatus</measure>
    <time_frame>daily during 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with adverse events</measure>
    <time_frame>daily during 48 hours</time_frame>
    <description>nausea and vomiting, pruritus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative blood level of ropivacaine at day + 1 and day + 2</measure>
    <time_frame>daily during 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signs of intoxication to ropivacaine</measure>
    <time_frame>eventual reports</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine (in one arm); catheterization (in both).</intervention_name>
    <description>Parallel study with two groups:
ropivacaine (2 mg.mL-1), at the rate of 4 mL.hr-1 through two subcutaneous catheters lateral to the sternum, both alimented by an elastomeric pump.
same protocol, with normal saline instead of ropivacaine.</description>
    <arm_group_label>ropivacaine</arm_group_label>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled cardiac surgery.

        Exclusion Criteria:

          -  - surgery in emergency

          -  thoracotomy

          -  cardiac graft

          -  redo

          -  pregnancy

          -  patient's refusal

          -  minor or adult under legal protection

          -  psychiatric ongoing disease

          -  addiction to opiates

          -  ongoing opiate treatment

          -  inability to use a PCA device

          -  respiratory insuffiency (Vital capacity or maximal expired volume per sec. &lt; 50% of
             the expected value, or mean PAP &gt; 50 mmHg)

          -  intra-aortic balloon

          -  severe renal insuffiency

          -  history of allergy or intolerance to: morphine, acetaminophen, bupivacaine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vedat Eldjezi, MB</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/22266899</url>
  </link>
  <results_reference>
    <citation>Eljezi V, Dual√© C, Azarnoush K, Skrzypczak Y, Sautou V, Pereira B, Tsokanis I, Schoeffler P. The analgesic effects of a bilateral sternal infusion of ropivacaine after cardiac surgery. Reg Anesth Pain Med. 2012 Mar-Apr;37(2):166-74. doi: 10.1097/AAP.0b013e318240957f.</citation>
    <PMID>22266899</PMID>
  </results_reference>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2010</study_first_submitted>
  <study_first_submitted_qc>September 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2010</study_first_posted>
  <last_update_submitted>April 2, 2013</last_update_submitted>
  <last_update_submitted_qc>April 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sternotomy</keyword>
  <keyword>Pain</keyword>
  <keyword>Respiratory function</keyword>
  <keyword>Opiates</keyword>
  <keyword>Patient-controlled</keyword>
  <keyword>Scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

